It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.
Authors:
- Maarten BoersMBMaarten Boers
- Leanne IdzerdaLILeanne Idzerda
- John R. KirwanJKJohn R. Kirwan
- Tore K. KvienTKTore K. Kvien
- Peter S. TugwellPTPeter S. Tugwell
- Maxime DougadosMDMaxime Dougados
Open Access
- 1 August 2011
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 38 (8) , 1720-1727
Abstract
The OMERACT patient reported outcomes (PRO) working group evaluated the methodologies for measuring responsiveness to change at the Outcome Measures in Rheumatology (OMERACT) 10 meeting. The outcome measures used in PRO studies are often expressed as continuous data at the group level (e.g., mean change in pain on a 0–100 visual analog scale). This is difficult to interpret and cannot easily be translated to the individual level of response. When interpreting scores at the individual level, it is important to take into account the following 4 main concepts: (1) improvement; (2) status of well-being; (3) onset of action; and (4) sustainability. Information from clinical trials on how many patients showed a response, what the level of response was, and how many patients are doing well, would be extremely useful for physicians. The objective of this article is to outline how continuous data may be reported in a clinically relevant manner. We will describe 5 techniques of reporting continuous variables in clinical studies and discuss the relevance of each.Keywords
This publication has 52 references indexed in Scilit:
- Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practiceAnnals of the Rheumatic Diseases, 2010
- Newer Biological Agents in Rheumatoid ArthritisDrugs, 2010
- Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseasesAnnals of the Rheumatic Diseases, 2009
- Content and Criterion Validity of the Preliminary Core Dataset for Clinical Trials in Fibromyalgia SyndromeThe Journal of Rheumatology, 2009
- Spondyloarthritis Is Associated with Poor Function and Physical Health-Related Quality of LifeThe Journal of Rheumatology, 2009
- Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial dataAnnals of the Rheumatic Diseases, 2009
- Clinically important outcomes in low back painBest Practice & Research Clinical Rheumatology, 2005
- A comparison of the EQ‐5D and SF‐6D across seven patient groupsHealth Economics, 2004
- A Comparative Review of Generic Quality-of-Life InstrumentsPharmacoEconomics, 2000
- Determining Clinically Important Differences in Health Status MeasuresPharmacoEconomics, 1999